Member of Investment Committee @ Corporate Venture Fund for non-disclosed Corporate Parent (January 2024 - Present)
Angel Investor (seed to growth stage) @ several Healthtech and Life sciences companies (March 2022 - Present)
Member of the Board of Directors (Verwaltungsrat) @ (May 2022 - November 2025)
Partner, Healthcare @ (June 2022 - October 2024)
Head of Business Development @ Roche Diagnostics Information Solutions @ (July 2019 - May 2022)
Head of Partnering and Collaborations @ Roche Diagnostics Information Solutions @ (September 2016 - June 2019)
Roche Venture Fund Investment Director @ (April 2008 - August 2016)
Roche Venture Fund Investment Manager @ (April 2005 - April 2008)
Roche Venture Fund Investment Analyst @ (August 2002 - April 2005)
Board Member @ Viewics, Inc. (acquired by Roche) (June 2015 - July 2016)
Board Member @ (March 2015 - July 2016)
Board Representative @ (March 2009 - July 2016)
CFO @ Adello Inc (August 2013 - January 2014)
CFO @ Adello Group AG (February 2013 - January 2014)
Cofounder @ Apptraction (January 2011 - January 2012)
Head of Investment Management @ GSL Galli, Schneider & Lehner (January 2000 - March 2002)
Intern @ Invision AG (a member of Metro Group) (January 1997 - January 1997)
Simon Meier Education
University of St.Gallen 1994-1999
Kantonsschule Solothurn
Simon Meier Summary
Simon Meier, based in Basel, BS, CH, is currently a Chief Executive Officer at Oxford Cancer Analytics. Simon Meier brings experience from previous roles at IDUN Technologies, Corporate Venture Fund for non-disclosed Corporate Parent, several Healthtech and Life sciences companies and Komed Health AG. Simon Meier holds a 1994 - 1999 University of St.Gallen. Simon Meier has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Simon Meier?
Find contact details for 700 million professionals.